APG-1387
APG-1387, a bivalent SMAC mimetic and an IAP antagonist, blocks the activity of IAPs family proteins (XIAP, cIAP-1, cIAP-2, and ML-IAP) . APG-1387 induces degradation of cIAP-1 and XIAP proteins, as well as caspase-3 activation and PARP cleavage, which leads to apoptosis. APG-1387 can be used for the research of hepatocellular carcinoma, ovarian cancer, and nasopharyngeal carcinoma.
Product Specifications
CAS Number
1570231-89-8
Purity
>98% (HPLC)
Solubility
DMSO : 50 mg/mL (43.20 mM; Need ultrasonic)
Smiles
O=S (C1=CC=CC (S (=O) (N (C[C@@H]2NC ([C@@H] (NC) C) =O) CC[C@] (CC[C@H]3C (NC (C4=CC=CC=C4) C5=CC=CC=C5) =O) ([H]) N3C2=O) =O) =C1) (N (C[C@@H]6NC ([C@@H] (NC) C) =O) CC[C@] (CC[C@H]7C (NC (C8=CC=CC=C8) C9=CC=CC=C9) =O) ([H]) N7C6=O) =O
Molecular Formula
C??H??N??O??S?
Molecular Weight
1157.4
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog